HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer

Author： de Araujo Souza Patríícia Savio Sichero Laura Maciag Paulo Cesar

ISSN： 1479-6694

Source： Future Oncology, Vol.5, Iss.3, 2009-04, pp. : 359-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk

By Barbisan Gisela

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1549-1556

Springer Publishing Company

Access to resources Recommend Favorite

The role of MALAT1 correlates with HPV in cervical cancer

Oncology Letters, Vol. 7, Iss. 6, 2014-01 ,pp. : 2135-2141

Spandidos Publications

Access to resources Recommend Favorite

Role of the MTHFR polymorphisms in cancer risk modification and treatment

By Kim Young-In

Future Oncology, Vol. 5, Iss. 4, 2009-05 ,pp. : 523-542

Future Medicine

Access to resources Recommend Favorite

Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries)

By Hakama M.

Cancer Causes and Control, Vol. 11, Iss. 9, 2000-11 ,pp. : 783-790

Springer Publishing Company

Access to resources Recommend Favorite

Expression of high-risk HPV DNA and CK19 in pelvic lymph nodes in stage a-a cervical cancer and their clinical value

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1801-1806

Spandidos Publications

Access to resources Recommend Favorite